Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Sustento Inc. has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. The company's prosecution profile is streamlined, featuring 1 distinct examiner and 1 distinct art unit. This concentration implies that the company's current patenting efforts are focused on a specific biological or pharmaceutical innovation, which simplifies the management of its intellectual property assets at the patent office.
The busiest examiner for the company is HOFFMAN, SUSAN COE, who is managing 1 busiest examiner pending action. As the portfolio contains only 1 pending office action, this examiner is responsible for the entirety of the company's active prosecution workload. The fact that all activity is localized in 1 distinct art unit suggests a targeted approach to securing rights within a specific technical domain. By focusing on the feedback from 1 distinct examiner, Sustento Inc. can refine its prosecution strategy to meet the specific expectations of HOFFMAN, SUSAN COE, potentially leading to a more efficient path through the Biotechnology & Pharmaceuticals examination process.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HOFFMAN, SUSAN COE | 1 | 54.2% | +25.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18028882 | FOOD AND SUPPLEMENT FORMULATIONS | HOFFMAN, SUSAN COE | 13d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18028882 | FOOD AND SUPPLEMENT FORMULATIONS | HOFFMAN, SUSAN COE | 13d |
| Art Unit | Apps |
|---|---|
| 1655 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18028882 | FOOD AND SUPPLEMENT FORMULATIONS | HOFFMAN, SUSAN COE | 1655 | §101§102§103§112 | Non-Final OA | 13d | Pending | Mar 28, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial